Allworth Financial’s Inovio Pharmaceuticals INO Stock Holding History

Allworth Financial’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$52	Hold	47	–	–	﹤0.01%	5069
2026 Q1	$82	Hold	47	–	–	﹤0.01%	5023
2025 Q4	$82	Sell	47 -257	-85%	-$566	﹤0.01%	4801
2025 Q3	$712	Buy	304 +7	+2%	+$13	﹤0.01%	4352
2025 Q2	$605	Hold	297	–	–	﹤0.01%	4086
2025 Q1	$571	Hold	297	–	–	﹤0.01%	3645
2024 Q4	$669	Buy	297 +12	+4%	+$53	﹤0.01%	3525
2024 Q3	$1.65K	Buy	285 +4	+1%	+$33	﹤0.01%	3039
2024 Q2	$2.83K	Buy	281 +250	+806%	+$2.63K	﹤0.01%	2769
2024 Q1	$431	Hold	31	–	–	﹤0.01%	3319
2023 Q4	$192	Hold	31	–	–	﹤0.01%	3289
2023 Q3	$146	Hold	31	–	–	﹤0.01%	3269
2023 Q2	$168	Hold	31	–	–	﹤0.01%	3131
2023 Q1	$308	Buy	+31	New	+$528	﹤0.01%	2931
2018 Q4	–	Sell	-894	Closed	-$60K	–	896
2018 Q3	$60K	Buy	+894	New	+$49.8K	﹤0.01%	266

Other funds holding INO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Allworth Financial's INO Position: Q2 2026 in Review

Allworth Financial held its Inovio Pharmaceuticals (INO) position steady in Q2 2026 at 47 shares worth $52. The position accounts for ﹤0.01% of the portfolio, ranked #5069.

Allworth Financial first reported a position in INO in Q3 2018 and has held it in 15 quarters since. The position peaked at $60K in Q3 2018. 103 funds tracked by Wall St. Rank hold INO as of Q2 2026.

Allworth Financial held 47 shares of Inovio Pharmaceuticals worth $52 as of Q2 2026.
Allworth Financial left its Inovio Pharmaceuticals share count unchanged in Q2 2026.
Inovio Pharmaceuticals made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #5069 holding.
Allworth Financial first reported a position in Inovio Pharmaceuticals in Q3 2018 and has held it in 15 quarters since.
Allworth Financial's Inovio Pharmaceuticals position peaked at $60K in Q3 2018.
103 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.